Role of surfactant protein SP-D in the diagnosis of pulmonary complications in patients with combined thoracic injury

Authors

DOI:

https://doi.org/10.15587/2519-4798.2020.213870

Keywords:

combined thoracic trauma, surfactant, SP-D, pulmonary hypertension, respiratory function, complications, duration of treatment, intensive care, ceruloplasmin

Abstract

The aim: to evaluate the informativeness of the content of SP-D in the blood of patients with combined thoracic trauma as a marker of the severity of traumatic illness and the impact of the proposed modifications of the intensive care algorithm on treatment outcomes.

Material and methods. The basis of this study is a statistical analysis of the results of a comprehensive examination of 92 patients with thoracic trauma. Control points were 1st, 3rd, 7th and 12th day of treatment. The severity of the injury was determined according to the ISS scale, the condition of patients at the time of admission according to the ARASNE II scale, the level of SP-D in the blood, the degree of pulmonary hypertension, the number of bed-days in the intensive care unit (IC). 3 groups of patients were identified. Group I - standard IC protocol, group II - standard IC protocol with the addition of ceruloplasmin, group III - standard IC protocol with the addition of a solution of D-fructose-1,6-diphosphate sodium salt of hydrate. Parametric statistics methods were used to process the obtained data.

Results. In patients of group I, the maximum numbers of SP-D in the blood were determined, which had a positive strong correlation during the entire observation period with the frequency of pulmonary complications and the duration of treatment in the IC department. In group II, the administration of ceruloplasmin neutralized the negative effect of oxidative stress on the surfactant, so the average SP-D in the blood only on the 3rd day exceeded the reference values by 20 %, which affected the lack of correlations between pulmonary parenchyma and duration of treatment. In group III, the addition of a solution of D-fructose-1,6-diphosphate sodium salt hydrate had a positive effect on the general condition of patients as a whole, but throughout the study period SP-D figures in the blood exceeded the starting and reference, which affected the presence of strong and medium positive correlation between them, the degree of pulmonary hypertension and the length of stay in the IC department.

Conclusions. In patients with combined thoracic trauma, it is important when planning patient management tactics to diagnose the content of surfactant protein SP-D in the blood during the entire period of stay in the intensive care unit. The level of SP-D in the blood of patients with combined thoracic trauma is a highly informative diagnostic marker of the functional state of the lung parenchyma (surfactant). An increase in its numbers three times indicates the beginning of the development of acute lung injury syndrome (exudative phase). Reduction of its figures in the course of respiratory distress syndrome by half the values in the exudative phase indicates the beginning of the proliferative phase and improvement of patients. The leading mechanism for the development of acute lung injury syndrome in patients with combined thoracic trauma. There is oxidative stress, so the appointment of ceruloplasmin as an adjunct to the standard protocol of intensive care is pathogenetically justified

Author Biographies

Olena Boiko, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

Assistant

Department of Emergency Medicine, Anesthesiology and Intensive Care

Yuliya Volkova, Kharkiv National Medical University Nauky ave., 4, Kharkiv, Ukraine, 61022

MD, Professor, Head of Department

Department of Emergency Medicine, Anesthesiology and Intensive Care

References

  1. Schulz-Drost, S. (2018). Thoracic trauma: Current aspects on interdisciplinary management of thoracic wall and organ injuries. Der Unfallchirurg, 121 (8), 594–595. doi: http://doi.org/10.1007/s00113-018-0531-6
  2. Sridhar, S., Raptis, C., Bhalla, S. (2016). Imaging of Blunt Thoracic Trauma. Seminars in Roentgenology, 51 (3), 203–214. doi: http://doi.org/10.1053/j.ro.2015.12.002
  3. Khatiban, M., Shirani, F., Oshvandi, K., Soltanian, A. R., Ebrahimian, R. (2018). Orem’s Self-Care Model With Trauma Patients: A Quasi-Experimental Study. Nursing Science Quarterly, 31 (3), 272–278. doi: http://doi.org/10.1177/0894318418774876
  4. Budassi, S. A. (1978). Chest trauma. Nursing Clinics of North America, 13 (3), 533–541.
  5. Ozel, S. K., Ozel, H. B., Colakoğlu, N., Ilhan, N., Arslan, N., Ozan, E. (2010). Protective effect of the thoracic cage on parenchyma in response to trauma direction in blunt thoracic trauma: an experimental study. Turkish journal of trauma & emergency surgery, 16 (4), 287–292.
  6. Battle, C., Hutchings, H., Bouamra, O., Evans, P. A. (2014). The Effect of Pre-Injury Anti-Platelet Therapy on the Development of Complications in Isolated Blunt Chest Wall Trauma: A Retrospective Study. PLoS ONE, 9 (3), e91284. doi: http://doi.org/10.1371/journal.pone.0091284
  7. Schulz-Drost, S., Ekkernkamp, A., Stengel, D. (2018). Epidemiologie, Verletzungsentitäten und Behandlungspraxis der Thoraxwandverletzungen. Der Unfallchirurg, 121 (8), 605–614. doi: http://doi.org/10.1007/s00113-018-0532-5
  8. Barkagan, Z. S., Momot, A. P. (2005). Sovremennye aspekty patogeneza, diagnostiki i terapii DVS sindroma. Vestnik Gematologii, 1 (2), 5–14.
  9. Kuznietsova, I. V. (2009). Patohenetychne obhruntuvannia pryntsypiv intensyvnoi terapii u khvorykh v krytychnykh stanakh riznoho genezu. Donetsk: Donetskyi natsionalnyi universytet, 39.
  10. Robles, A. J., Kornblith, L. Z., Hendrickson, C. M., Howard, B. M., Conroy, A. S., Moazed, F. et. al. (2018). Health care utilization and the cost of posttraumatic acute respiratory distress syndrome care. Journal of Trauma and Acute Care Surgery, 85 (1), 148–154. doi: http://doi.org/10.1097/ta.0000000000001926
  11. Hrubnyk, V. V. (2014). Krytychni stany u khirurhichnykh khvorykh: hostryi respiratornyi dystres syndrom, koma, syndrom cherevnoi porozhnyny, kolaps. Odessa: ONMU, 36.
  12. Robba, C., Ortu, A., Bilotta, F., Lombardo, A., Sekhon, M. S., Gallo, F., Matta, B. F. (2017). Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients. Journal of Trauma and Acute Care Surgery, 82 (1), 165–173. doi: http://doi.org/10.1097/ta.0000000000001276
  13. Birkun, A. A., Osunsanya, O. O. (2016). Acute Respiratory Failure. Emergency medicine, 7 (78), 102–108. doi: http://doi.org/10.22141/2224-0586.7.78.2016.86102
  14. Gelfand, B. R., Iaroshetskii, A. I., Protsenko, D. N., Ignatenko, O. V., Lapshina, I. Iu., Gelfand, E. B. (2014). Parenkhimatoznaia dykhatelnaia nedostatochnost u bolnykh v kriticheskikh sostoianiiakh: vsegda li eto ostrii respiratornii distress-sindrom? Vestnik intensivnoi terapii, 4, 3–9.
  15. Gradil, G. I., Gubina-Vakulik, G. I., Mogilenets, E. I., Antsiferova, N. V., Amelina, L. M., Iurchenko, I. S. (2015). Gripp A (H1N1) pdm, ostrii respiratornii distress-sindrom ili pnevmoniia: sravnitelnii kliniko-morfologicheskii analiz dvukh letalnykh sluchaev. Eksperimentalna і klіnіchna meditsina, 4, 64–73.
  16. Kassil, V. L., Sapicheva, Iu. Iu. (2009). Ostrii respiratornii distress-sindrom i gipoksemiia. Moscow: MEDpress-inform, 150.
  17. Satsuta, S. V., Bondariev, R. V. (2009). Dyferentsiiovanyi pidkhid do intensyvnoi respiratornoi terapii pry syndromi hostroho poshkodzhennia leheniv u postrazhdalykh z politravmoiu. Problemy viiskovoi okhorony zdorov`ya, 34 (2), 355–360.
  18. Maltseva, L. O., Mosentsev, M. F., Mishchenko, O. A., Borzova, A. V., Perederii, M. M. (2015). New Respiratory and Hemodynamic Strategies of the Revised Berlin Definitions of the Acute Respiratory Distress Syndrome. Emergency Medicine, 4 (75), 92–95. doi: http://doi.org/10.22141/2224-0586.4.75.2016.75824
  19. Maltseva, L. O., Mosentsev, M. F., Bazylenko, D. V., Bilan, O. M., Kunik, L. V. (2016). Respiratory Distress Syndrome: Current Issues of Definitions, Clinical Presentation, Diagnostic Algorithm. Emergency Medicine, 4 (75), 108–110. doi: http://doi.org/10.22141/2224-0586.4.75.2016.75827
  20. Surfaktant. Poverkhnostnoe natiazhenye y spadenye alveol. Available at: http://meduniver.com/Medical/Physiology/847.html
  21. Novikov, N. Iu., Tyshkevich, L. V., Dzhansyz, K. N. (2012). Patomorfologicheskie izmeneniia aerogematicheskogo barera pri ostrom respiratornom distress-sindrome v eksperimente. Patologіia, 1, 53–56.
  22. Potapov, A. L., Novikov, N. Iu., Tumanskii, V. A., Babanin, A. A. (2013). Vliianie zamestitelnoi surfaktantnoi terapii na prodolzhitelnost zhizni patsientov pri ostrom respiratornom distress-sindrome. Klіnіchna khіrurgіia, 2, 57–59.
  23. Dobrorodnyi, A. V. (2012). Patohenetychni mekhanizmy rozvytku kysnevoi nedostatnosti pry hostromu respiratornomu dystres-syndromi ta yii korektsiia antyhipoksantomy (eksperymentalne doslizhdzhennia). Ternopil: Ternopilskyi derzh. med. un-t im. I.Ya. Horbachevskoho, 20.
  24. Ibadov, R. A., Nazirova, L. A., Khudaybergenov, Sh. N., Abrolov, H. K., Arifdjanov, A. Sh., Strijkov N. A. et. al. (2016). A single lung acute respiratory distress sindrome: case report. Annals of critical care, 1, 57–60.
  25. Schreiter, D., Carvalho, N. C., Katscher, S., Mende, L., Reske, A. P., Spieth, P. M. et. al. (2015). Experimental blunt chest trauma – cardiorespiratory effects of different mechanical ventilation strategies with high positive end-expiratory pressure: a randomized controlled study. BMC Anesthesiology, 16 (1). doi: http://doi.org/10.1186/s12871-015-0166-x
  26. Croce, M. A., Brasel, K. J., Coimbra, R., Adams, C. A., Miller, P. R., Pasquale, M. D. et. al. (2013). National Trauma Institute prospective evaluation of the ventilator bundle in trauma patients: does it really work? Journal of Trauma and Acute Care Surgery, 74 (2), 354–362. doi: http://doi.org/10.1097/ta.0b013e31827a0c65
  27. Miller, M. R., Hankinson, J., Brusasco, V. et. al. (2005). Standardization of spirometry. European Respiratory Journal, 26 (2), 319–338. doi: http://doi.org/10.1183/09031936.05.00034805
  28. Avrunin, O. G., Tomashevskii, R. S., Faruk, Kh. I. (2015). Metody i sredstva funktsionalnoi diagnostiki vneshnego dykhaniia. Kharkov. KHNADU, 231.
  29. Reguliatsiia dykhaniia. Available at: http://kineziolog.su/content/regulyaciya-dyhaniya
  30. Liamyna, S. V., Vedenikin, T. Yu., Malyshev, I. Yu. (2011). Suchasnyi pidkhid do analizu imunnoi vidpovidi pry zakhvoriuvanniakh lehen: surfaktantnoho bilok d i yoho rol. Suchasni problemy nauky ta osvity, 4, 2–10. Available at: http://www.science-education.ru/ru/article/view?id=4717
  31. Kalmatov, R. K., Zholdoshev, S. T., Karimova, N. A. (2015). Patogeneticheskaia rol surfaktantnogo proteina sp-d pri zabolevaniiakh legkikh i dykhatelnykh putei. Fundamentalnye issledovaniia, 1-8, 1591–1595.
  32. Liamyna, S. V., Malyshev, I. Yu. (2012). Surfaktantnyi bilok d v normi i pry zakhvoriuvanniakh leheniv. Rosiiskyi medychnyi zhurnal, 1, 50–55.
  33. Crouch, E., Persson, A., Chang, D. (1993). Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. American Journal of Pathology, 142, 241–248.
  34. Atochina-Vasserman, E. N., Beers, M. F., Kadire, H., Tomer, Y., Inch, A., Scott, P. et. al. (2007). Selective Inhibition of Inducible NO Synthase Activity In Vivo Reverses Inflammatory Abnormalities in Surfactant Protein D-Deficient Mice. The Journal of Immunology, 179 (12), 8090–8097. doi: http://doi.org/10.4049/jimmunol.179.12.8090
  35. Determann, R. M., Royakkers, A. A., Haitsma, J. J., Zhang, H., Slutsky, A. S., Ranieri, V. M., Schultz, M. J. (2010). Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulmonary Medicine, 10 (1). doi: http://doi.org/10.1186/1471-2466-10-6
  36. Liamina, S. V., Kruglov, S. V., Vedenikin T. Iu., Malyshev I. Iu. (2011). Novaia strategiia upravleniia immunnym otvetom pri zabolevaniiakh legkikh – rol surfaktantnogo belka D kak bivalentnogo faktora reprogrammirovaniia makrofagov. Fundamentalnye issledovaniia, 1, 90–98.
  37. Vasserman, E. N., Liamina, S. V., Shimshelashvili, Sh. L. et. al. (2010). SP-D kontroliruet balans Th1 i Th2 tsitokinov i obladaet priznakami endogennogo faktora reprogrammirovaniia makrofagov. Fundamentalnye issledovaniia, 6, 28–36.
  38. Kati, C., Alacam, H., Duran, L., Guzel, A., Akdemir, H., Sisman, B. et. al. (2014).The effectiveness of the serum surfactant protein D (Sp-D) level to indicate lung injury in pulmonary embolism. Clinical Laboratory, 60 (9), 1457–1364. doi: http://doi.org/10.7754/clin.lab.2013.131009
  39. Cheng, G., Ueda, T., Numao, T., Kuroki, Y., Nakajima, H., Fukushima, Y. et. al. (2000). Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. European Respiratory Journal, 16 (5), 831–835. doi: http://doi.org/10.1183/09031936.00.16583100

Downloads

Published

2020-09-30

How to Cite

Boiko, O., & Volkova, Y. (2020). Role of surfactant protein SP-D in the diagnosis of pulmonary complications in patients with combined thoracic injury. ScienceRise: Medical Science, (5 (38), 24–30. https://doi.org/10.15587/2519-4798.2020.213870

Issue

Section

Medical Science